Divis Laboratories Ltd | DIVI - Operating Profit



Divis Laboratories Ltd reported 6.17B in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Alaunos Therapeutics USD -755000 395K Dec/2024
Aurobindo Pharma INR 13.47B 190.8M Mar/2025
Avita Medical AUD -9957000 5.64M Dec/2024
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Divis Laboratories Ltd 6.17B 1.62B Jun/2025
Ionis Pharmaceuticals USD 139.84M 285.84M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
Lupin INR 13.42B 4.43B Jun/2025
Moderna USD -907000000 143M Jun/2025
Organon & Co USD 326M 225M Jun/2025
Revvity USD 90.76M 18.53M Jun/2025
Tectonic Therapeutic USD -22330000 8.34M Jun/2025
Tilray USD -42218000 5.65M Nov/2024
Viatris USD 185.4M 3.21B Jun/2025
Xeris Pharmaceuticals USD 4.48M 2.8M Jun/2025